0000899243-20-026099.txt : 20200923
0000899243-20-026099.hdr.sgml : 20200923
20200923170101
ACCESSION NUMBER: 0000899243-20-026099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200921
FILED AS OF DATE: 20200923
DATE AS OF CHANGE: 20200923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnston David Michael
CENTRAL INDEX KEY: 0001802057
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39212
FILM NUMBER: 201192586
MAIL ADDRESS:
STREET 1: C/O PPD, INC.
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PPD, Inc.
CENTRAL INDEX KEY: 0001793294
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 453806427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401-3331
BUSINESS PHONE: 910 251 0081
MAIL ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401-3331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-21
0
0001793294
PPD, Inc.
PPD
0001802057
Johnston David Michael
C/O PPD, INC.
929 NORTH FRONT STREET
WILMINGTON
NC
28401
0
1
0
0
See Remarks
Common stock
2020-09-21
4
S
0
40000
33.11
D
53107
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.23, inclusive. The reporting person undertakes to provide to PPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Title: EVP of Global Clinical Development
/s/ Richard Whitlow, as Attorney-in-Fact
2020-09-23